BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30863319)

  • 1. MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
    Li C; Morvaridi S; Lam G; Chheda C; Kamata Y; Katsumata M; Edderkaoui M; Yuan X; Nissen N; Pandol SJ; Wang Q
    Front Physiol; 2019; 10():147. PubMed ID: 30863319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutational status of RON in neoplastic lesions of the breast: analysis of MSP/RON signaling in ductal carcinoma in situ and invasive ductal carcinoma.
    Ren X; Daa T; Yada N; Kashima K; Fujitomi Y; Yokoyama S
    APMIS; 2012 May; 120(5):358-67. PubMed ID: 22515290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.
    Thomas RM; Toney K; Fenoglio-Preiser C; Revelo-Penafiel MP; Hingorani SR; Tuveson DA; Waltz SE; Lowy AM
    Cancer Res; 2007 Jul; 67(13):6075-82. PubMed ID: 17616662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
    Feres KJ; Ischenko I; Hayman MJ
    Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis.
    Ikezawa K; Hikita H; Shigekawa M; Iwahashi K; Eguchi H; Sakamori R; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):185-200.e1. PubMed ID: 28948203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network map of macrophage-stimulating protein (MSP) signaling.
    Sanjeev D; Dagamajalu S; Shaji V; George M; Subbannayya Y; Prasad TSK; Raju R; Devasahayam Arokia Balaya R
    J Cell Commun Signal; 2023 Sep; 17(3):1113-1120. PubMed ID: 37142846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of RON receptor kinase delays but does not prevent tumor progression while enhancing HGF/MET signaling in pancreatic cancer cell lines.
    Zhao S; Cao L; Freeman JW
    Oncogenesis; 2013 Oct; 2(10):e76. PubMed ID: 24100611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
    Vanderwerff BR; Church KJ; Kawas LH; Harding JW
    Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi).
    Zou Y; Howell GM; Humphrey LE; Wang J; Brattain MG
    PLoS One; 2013; 8(7):e69992. PubMed ID: 23922886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
    Lu T; Wang Z; Prativa S; Xu Y; Wang T; Zhang Y; Yu L; Xu N; Tang J; You W; Chen G; Zhang JH
    J Neurochem; 2019 Jan; 148(1):114-126. PubMed ID: 30380151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin.
    Damalanka VC; Wildman SA; Janetka JW
    Medchemcomm; 2019 Sep; 10(9):1646-1655. PubMed ID: 31803403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor.
    Montero-Julian FA; Dauny I; Flavetta S; Ronsin C; André F; Xerri L; Wang MH; Marvaldi J; Breathnach R; Brailly H
    Hybridoma; 1998 Dec; 17(6):541-51. PubMed ID: 9890710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
    Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
    J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).
    Zińczuk J; Zaręba K; Romaniuk W; Kamińska D; Nizioł M; Baszun M; Kędra B; Guzińska-Ustymowicz K; Pryczynicz A
    Int J Med Sci; 2019; 16(4):583-592. PubMed ID: 31171910
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.
    Kauder SE; Santell L; Mai E; Wright LY; Luis E; N'Diaye EN; Lutman J; Ratti N; Sa SM; Maun HR; Stefanich E; Gonzalez LC; Graham RR; Diehl L; Faubion WA; Keir ME; Young J; Chaudhuri A; Lazarus RA; Egen JG
    PLoS One; 2013; 8(12):e83958. PubMed ID: 24409221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.